Endogenex announced today that it completed enrollment in the ReCET clinical study of its endoscopic diabetes treatment. ReCET enrolled 350 patients across approximately 40 clinical sites in the U.S. and Australia. It evaluates the safety and effectiveness of the Endogenex System in adult patients with T2D whose blood glucose levels are inadequately controlled with non-insulin […]
MassDevice Diabetes Hub
MassDevice's Diabetes Hub is your resource for the latest news in diabetes technology. Stay informed about the innovations and business news shaping the diabetes device industry.
Check out our latest feature:
Here are more top diabetes features from MassDevice, Drug Delivery Business News and sibling publications (and scroll down to read the latest diabetes device news from MassDevice):
+ 12 things you need to know about the CGM market
+ Our first Medtech Market Intelligence Report takes a deep dive into the CGM space
+ Download our 2025 Diabetes Technology Special Report
+ The biggest diabetes tech stories out of ADA 2025
+ Abbott could pave new roads in diabetes management with dual sensor on the horizon
+ Omnipod 5 rollout for type 2 advances as Insulet pursues next-gen automation
+ This minimally invasive diabetes device delivers pulsed field energy in the gut
+ Diabetes device developers turn their sights to type 2
+ How Dexcom designed a new “life-changing” sensor for even more people with diabetes
Latest Diabetes News
Insulet launches Omnipod 5, Omnipod Discover in Spain
Insulet (Nasdaq:PODD) announced today that it launched its Omnipod 5 insulin pump and Omnipod Discover platform in Spain. With the launch, Spain becomes the 26th country in which Insulet sells Omnipod and the 20th reached by Omnipod 5, the company’s latest-generation patch-based automated insulin delivery system. Omnipod 5 became the world’s first available tubeless, wearable, […]
Trinity Biotech reports positive clinical findings for next-gen CGM
Trinity Biotech (Nasdaq:TRIB) today announced new clinical findings supporting its next-generation continuous glucose monitor (CGM). Dublin, Ireland-based Trinity unveiled the CGM+ next-gen wearable biosensor in July 2025. With CGM+, the company aims to take on the growing AI wearables market. The company said it has the system in the later stages of device development. The new […]
Tandem Diabetes Care launches t:slim X2 pump with Abbott FreeStyle Libre 3 Plus in new geographies
Tandem Diabetes Care (Nasdaq:TNDM) announced today that it launched the t:slim X2 insulin pump with the Abbott FreeStyle Libre 3 Plus in five new countries. San Diego-based Tandem launched the pairing of its flagship automated insulin delivery system with Control-IQ+ technology with Abbott’s latest continuous glucose monitor (CGM) sensor in the U.S. in October 2025. […]
Terrestrial Bio doses first patients in GLP-1 patch trial
Terrestrial Bio announced today that it dosed the first patients in a Phase I clinical trial evaluating its patch that delivers GLP-1 therapeutic semaglutide. Boston-based Terrestrial (formerly Vaxess Technologies) is evaluating VX-201, a needle-free microarray patch (MAP) in the trial. The company designed its MAP technology features a soluble microarray with tips that gradually dissolve into […]
MiniMed adds Alcon CEO, Medtronic exec to board of directors
MiniMed (Nasdaq:MMED) announced today that it appointed David Endicott and Linnea Burman to its board of directors, effective today. The appointments of Endicott and Burman expand the board from nine members to 11 members. Endicott, currently the CEO of Alcon, also joins the board’s Compensation and Talent Committee with the appointment. Northridge, California-based MiniMed’s latest […]
Modular Medical launches Pivot tubeless insulin patch pump
Modular Medical (Nasdaq:MODD) announced today that it commercially launched its new Pivot tubeless insulin patch pump. The rollout marks the start of real-world patient use of the Pivot pump. It marks San Diego-based Modular Medical’s transition to a commercial-stage medical device company. Modular Medical designed Pivot to make insulin pump therapy simpler to learn and […]
Dexcom launches enhanced Stelo app
Dexcom (Nadsaq:DXCM) today announced the launch of its fully reimagined Stelo over-the-counter (OTC) sensor app experience. San Diego-based Dexcom plans to formally begin the new app rollout in July for Apple iPhone and Android users in the U.S. The company At ADA 2026, Dexcom said it planned to offer select users the opportunity for early […]
MiniMed launches Instinct sensors made by Abbott with insulin delivery tech in Europe
MiniMed (Nasdaq:MMED) announced today that it launched two insulin delivery platforms with the Instinct sensor made by Abbott in Europe. The Northridge, California-based former Medtronic Diabetes unit launched its MiniMed 780G automated insulin delivery system integrated with Instinct, along with the MiniMed Go system paired with the Instinct Go sensor. Both sensors, made by Abbott […]
Insulet has a new chief R&D officer
Insulet (Nasdaq:PODD) announced today on social media that it appointed Dr. Divakar Ramakrishnan as its new chief R&D officer. In a LinkedIn post, the company said Ramakrishnan will lead its R&D organization. His focus centers around strengthening Insulet’s capabilities in delivering innovation around the world. Ramakrishnan joins as the company continues to advance its automated […]
MiniMed begins miniature Flex pump rollout in US
MiniMed (Nasdaq:MMED) announced today that it kicked off its first commercial launch of its Flex automated insulin delivery system in the U.S. The launch comes a few months after the system picked up FDA clearance in March. Northridge, California-based MiniMed, the former Medtronic Diabetes unit, designed Flex, its smallest insulin pump yet, as its first […]
